Literature DB >> 34211285

Analysis of Nosocomial Infection and Risk Factors in Patients with ECMO Treatment.

Zhan-Jie Li1, Dong-Fang Zhang2, Wei-Hong Zhang3.   

Abstract

OBJECTIVE: To investigate the drug resistance of nosocomial infection-related pathogens in patients who underwent extracorporeal membrane oxygenation (ECMO), analyzing the nosocomial infection-related risk factors.
METHODS: The medical records of 56 patients who received ECMO support treatment in the First Affiliated Hospital with Nanjing Medical University from January 2013 to December 2019 were selected. The nosocomial infection, pathogen distribution and drug resistance, and the influencing factors of nosocomial infection were analyzed. The predictive value of independent risk factors for nosocomial infection after ECMO was analyzed using the receiver operating characteristic (ROC) curve.
RESULTS: A total of 56 patients receiving ECMO treatment were included. The nosocomial infection rate was 28.57%, and the prevalence infection rate was 44.64%. Lower respiratory tract infection was the main infection site. Among these infectious patients, 53 strains of pathogens were detected. The results showed that the gram-negative bacteria were mainly Acinetobacter baumannii and Klebsiella pneumonia. Moreover, the drug resistance rate of Acinetobacter baumannii to most of the antibiotics was more than 65%, among which the drug resistance rate to carbapenems was 80%. The results of risk factors of nosocomial infection after ECMO were analyzed by univariate analysis, showing that ECMO treatment time, hospitalization time, antibacterial drug use time, ventilator use time, catheter intubation time and central venous intubation time were statistically significant (all p < 0.001). Multivariate analysis identified that ECMO treatment time was an independent risk factor. As showed by ROC curve, ECMO treatment time had a high predictive value for postoperative nosocomial infection. ECMO treatment times of more than 4.5 days were associated with an increased risk of nosocomial infection.
CONCLUSION: The nosocomial infection rate after ECMO was relatively high, and the main pathogens are Gram-negative bacteria. The selection of antibiotics should be based on the results of pathogen drug sensitivity.
© 2021 Li et al.

Entities:  

Keywords:  extracorporeal membrane oxygenation; infection site; nosocomial infection; risk factors

Year:  2021        PMID: 34211285      PMCID: PMC8241808          DOI: 10.2147/IDR.S306209

Source DB:  PubMed          Journal:  Infect Drug Resist        ISSN: 1178-6973            Impact factor:   4.003


  17 in total

Review 1.  A meta-analysis of complications and mortality of extracorporeal membrane oxygenation.

Authors:  Alberto Zangrillo; Giovanni Landoni; Giuseppe Biondi-Zoccai; Massimiliano Greco; Teresa Greco; Giacomo Frati; Nicolò Patroniti; Massimo Antonelli; Antonio Pesenti; Federico Pappalardo
Journal:  Crit Care Resusc       Date:  2013-09       Impact factor: 2.159

2.  Reducing Broad Spectrum Antimicrobial Use in Extracorporeal Membrane Oxygenation (ECMO): Reduce AMMO Study.

Authors:  Aditya Shah; Priya Sampathkumar; Ryan W Stevens; John K Bohman; Brian D Lahr; Prabij Dhungana; Kirtivardhan Vashistha; John C O'Horo
Journal:  Clin Infect Dis       Date:  2021-02-12       Impact factor: 9.079

3.  Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome). Use of the Bramson membrane lung.

Authors:  J D Hill; T G O'Brien; J J Murray; L Dontigny; M L Bramson; J J Osborn; F Gerbode
Journal:  N Engl J Med       Date:  1972-03-23       Impact factor: 91.245

Review 4.  The Evidence Base for Prophylactic Antibiotics in Patients Receiving Extracorporeal Membrane Oxygenation.

Authors:  John C O'Horo; Kelly A Cawcutt; Alice Gallo De Moraes; Priya Sampathkumar; Gregory J Schears
Journal:  ASAIO J       Date:  2016 Jan-Feb       Impact factor: 2.872

5.  Analysis of Nosocomial Infections in Post-Cardiac Surgery Extracorporeal Membrane Oxygenation Support Therapy.

Authors:  Binfei Li; Geqin Sun; Zhou Cheng; Chuangchuang Mei; Xiaozu Liao; Jianwei Li; Yong Yuan
Journal:  Heart Surg Forum       Date:  2018-09-17       Impact factor: 0.676

Review 6.  Extracorporeal membrane oxygenation for ARDS in adults.

Authors:  Daniel Brodie; Matthew Bacchetta
Journal:  N Engl J Med       Date:  2011-11-17       Impact factor: 91.245

7.  How should we treat acinetobacter pneumonia?

Authors:  Rosario Amaya-Villar; José Garnacho-Montero
Journal:  Curr Opin Crit Care       Date:  2019-10       Impact factor: 3.687

8.  Extracorporeal membrane oxygenation line-associated complications: in vitro testing of cyanoacrylate tissue adhesive and securement devices to prevent infection and dislodgement.

Authors:  Taressa Bull; Amanda Corley; Danielle J Smyth; David J McMillan; Kimble R Dunster; John F Fraser
Journal:  Intensive Care Med Exp       Date:  2018-03-12

Review 9.  Left ventricular unloading during veno-arterial ECMO: a review of percutaneous and surgical unloading interventions.

Authors:  Dirk W Donker; Daniel Brodie; José P S Henriques; Michael Broomé
Journal:  Perfusion       Date:  2018-08-16       Impact factor: 1.972

10.  Risk factors and prognosis of nosocomial pneumonia in patients undergoing extracorporeal membrane oxygenation: a retrospective study.

Authors:  Jianrong Wang; Jinyu Huang; Wei Hu; Xueying Cai; Weihang Hu; Ying Zhu
Journal:  J Int Med Res       Date:  2020-10       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.